Log In
BCIQ
Print this Print this
 

Ellence, epirubicin

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionEpirubicin
Molecular Target DNA
Mechanism of ActionTopoisomerase II inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationBreast cancer
Indication DetailsTreat early breast cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today